25 XP   0   0   10

Pyridam Farma Tbk
Buy, Hold or Sell?

Let's analyse Pyridam Farma Tbk together

PenkeI guess you are interested in Pyridam Farma Tbk. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pyridam Farma Tbk. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pyridam Farma Tbk

I send you an email if I find something interesting about Pyridam Farma Tbk.

Quick analysis of Pyridam Farma Tbk (30 sec.)










What can you expect buying and holding a share of Pyridam Farma Tbk? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.00
When do you have the money?
1 year
How often do you get paid?
22.5%

What is your share worth?

Current worth
Rp143.27
Expected worth in 1 year
Rp109.14
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
Rp-34.13
Return On Investment
-33.8%

For what price can you sell your share?

Current Price per Share
Rp101.00
Expected price per share
Rp0 - Rp975.00
How sure are you?
50%

1. Valuation of Pyridam Farma Tbk (5 min.)




Live pricePrice per Share (EOD)

Rp101.00

Intrinsic Value Per Share

Rp-2,381.99 - Rp-1,026.06

Total Value Per Share

Rp-2,238.72 - Rp-882.78

2. Growth of Pyridam Farma Tbk (5 min.)




Is Pyridam Farma Tbk growing?

Current yearPrevious yearGrowGrow %
How rich?$35.7m$31m$8.6m21.7%

How much money is Pyridam Farma Tbk making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m$6.8m-$9m-423.0%
Net Profit Margin-12.5%28.2%--

How much money comes from the company's main activities?

3. Financial Health of Pyridam Farma Tbk (5 min.)




What can you expect buying and holding a share of Pyridam Farma Tbk? (5 min.)

Welcome investor! Pyridam Farma Tbk's management wants to use your money to grow the business. In return you get a share of Pyridam Farma Tbk.

What can you expect buying and holding a share of Pyridam Farma Tbk?

First you should know what it really means to hold a share of Pyridam Farma Tbk. And how you can make/lose money.

Speculation

The Price per Share of Pyridam Farma Tbk is Rp101.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pyridam Farma Tbk.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pyridam Farma Tbk, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp143.27. Based on the TTM, the Book Value Change Per Share is Rp-8.53 per quarter. Based on the YOY, the Book Value Change Per Share is Rp27.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pyridam Farma Tbk.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.11-0.09-0.10-0.07-0.04-
Price to Earnings Ratio-17.96--34.21-77.42-2.09-82.30-
Price-to-Total Gains Ratio-72.11--136.91-306.91--28.79-208.67-
Price to Book Ratio7.99-5.70-9.77-9.04-6.30-
Price-to-Total Gains Ratio-72.11--136.91-306.91--28.79-208.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0101
Number of shares99009
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (99009 shares)-84.4949.00
Gains per Year (99009 shares)-337.95196.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-338-3487189186
20-676-68614378382
30-1014-102420568578
40-1352-136227757774
50-1690-170034946970
60-2028-20384111351166
70-2366-23764813241362
80-2704-27145415141558
90-3042-30526117031754
100-3380-33906818921950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%6.06.00.050.0%13.07.00.065.0%29.07.04.072.5%56.07.016.070.9%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%13.07.00.065.0%28.012.00.070.0%55.023.01.069.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%4.00.016.020.0%9.00.031.022.5%9.00.070.011.4%
Total Gains per Share0.04.00.00.0%6.06.00.050.0%13.07.00.065.0%29.011.00.072.5%56.022.01.070.9%

Fundamentals of Pyridam Farma Tbk

About Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates in two segments, Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR " extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; medical support products; over the counter, ethical, and sigma products in the areas of musculo-skeletal, cardiovascular and hematopoietic system, genito urinary system, and respiratory system, as well as mineral and health supplements, vitamins, and other consumer health products in the form of syrups, tablets, and capsules; and sanitizers and antiseptics. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta, Indonesia.

Fundamental data was last updated by Penke on 2024-04-24 16:53:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pyridam Farma Tbk.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pyridam Farma Tbk earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -21.9% means that Rp-0.22 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pyridam Farma Tbk:

  • The MRQ is -21.9%. The company is making a huge loss. -2
  • The TTM is -12.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21.9%TTM-12.5%-9.4%
TTM-12.5%YOY28.2%-40.7%
TTM-12.5%5Y5.8%-18.3%
5Y5.8%10Y4.1%+1.7%
1.1.2. Return on Assets

Shows how efficient Pyridam Farma Tbk is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Pyridam Farma Tbk generated Rp-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pyridam Farma Tbk:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-1.4%-1.2%
TTM-1.4%YOY4.6%-6.0%
TTM-1.4%5Y1.5%-2.9%
5Y1.5%10Y1.1%+0.3%
1.1.3. Return on Equity

Shows how efficient Pyridam Farma Tbk is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • -11.1% Return on Equity means Pyridam Farma Tbk generated Rp-0.11 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pyridam Farma Tbk:

  • The MRQ is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-5.6%-5.6%
TTM-5.6%YOY15.9%-21.4%
TTM-5.6%5Y3.4%-8.9%
5Y3.4%10Y2.4%+1.0%

1.2. Operating Efficiency of Pyridam Farma Tbk.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pyridam Farma Tbk is operating .

  • Measures how much profit Pyridam Farma Tbk makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated Rp0.00  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pyridam Farma Tbk:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY15.7%-15.7%
TTM-5Y8.5%-8.5%
5Y8.5%10Y4.7%+3.8%
1.2.2. Operating Ratio

Measures how efficient Pyridam Farma Tbk is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.67 means that the operating costs are Rp1.67 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Pyridam Farma Tbk:

  • The MRQ is 1.667. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.577. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.667TTM1.577+0.090
TTM1.577YOY1.611-0.034
TTM1.5775Y1.471+0.106
5Y1.47110Y0.954+0.517

1.3. Liquidity of Pyridam Farma Tbk.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pyridam Farma Tbk is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.94 means the company has Rp1.94 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Pyridam Farma Tbk:

  • The MRQ is 1.942. The company is able to pay all its short-term debts. +1
  • The TTM is 1.872. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.942TTM1.872+0.071
TTM1.872YOY2.249-0.378
TTM1.8725Y2.909-1.037
5Y2.90910Y1.591+1.318
1.3.2. Quick Ratio

Measures if Pyridam Farma Tbk is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.64 means the company can pay off Rp0.64 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pyridam Farma Tbk:

  • The MRQ is 0.642. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.827. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.642TTM0.827-0.184
TTM0.827YOY1.465-0.638
TTM0.8275Y2.046-1.219
5Y2.04610Y1.540+0.506

1.4. Solvency of Pyridam Farma Tbk.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pyridam Farma Tbk assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pyridam Farma Tbk to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.77 means that Pyridam Farma Tbk assets are financed with 76.5% credit (debt) and the remaining percentage (100% - 76.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pyridam Farma Tbk:

  • The MRQ is 0.765. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.739. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.765TTM0.739+0.027
TTM0.739YOY0.782-0.043
TTM0.7395Y0.591+0.148
5Y0.59110Y0.493+0.098
1.4.2. Debt to Equity Ratio

Measures if Pyridam Farma Tbk is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 326.3% means that company has Rp3.26 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pyridam Farma Tbk:

  • The MRQ is 3.263. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.848. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.263TTM2.848+0.415
TTM2.848YOY4.262-1.415
TTM2.8485Y2.191+0.657
5Y2.19110Y1.426+0.765

2. Market Valuation of Pyridam Farma Tbk

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Pyridam Farma Tbk generates.

  • Above 15 is considered overpriced but always compare Pyridam Farma Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -17.96 means the investor is paying Rp-17.96 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pyridam Farma Tbk:

  • The EOD is -1.584. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.958. Based on the earnings, the company is expensive. -2
  • The TTM is -34.210. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.584MRQ-17.958+16.374
MRQ-17.958TTM-34.210+16.251
TTM-34.210YOY77.415-111.625
TTM-34.2105Y2.094-36.304
5Y2.09410Y82.297-80.203
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pyridam Farma Tbk:

  • The EOD is -0.583. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.606. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.225. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.583MRQ-6.606+6.023
MRQ-6.606TTM-7.225+0.620
TTM-7.225YOY-6.544-0.681
TTM-7.2255Y25.528-32.754
5Y25.52810Y12.122+13.406
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pyridam Farma Tbk is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Pyridam Farma Tbk:

  • The EOD is 0.705. Based on the equity, the company is cheap. +2
  • The MRQ is 7.992. Based on the equity, the company is overpriced. -1
  • The TTM is 5.705. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.705MRQ7.992-7.287
MRQ7.992TTM5.705+2.287
TTM5.705YOY9.775-4.070
TTM5.7055Y9.038-3.333
5Y9.03810Y6.300+2.738
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pyridam Farma Tbk compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---15.878-8.533-46%27.589-158%4.778-432%2.640-701%
Book Value Per Share--143.272159.393-10%124.788+15%91.615+56%66.610+115%
Current Ratio--1.9421.872+4%2.249-14%2.909-33%1.591+22%
Debt To Asset Ratio--0.7650.739+4%0.782-2%0.591+30%0.493+55%
Debt To Equity Ratio--3.2632.848+15%4.262-23%2.191+49%1.426+129%
Dividend Per Share----0%-0%0.172-100%0.174-100%
Eps---15.940-8.549-46%27.610-158%4.657-442%2.614-710%
Free Cash Flow Per Share---43.334-12.804-70%-4.111-91%-6.895-84%-3.484-92%
Free Cash Flow To Equity Per Share---43.334-18.068-58%74.813-158%18.193-338%12.150-457%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---1026.056--------
Intrinsic Value_10Y_min---2381.989--------
Intrinsic Value_1Y_max---26.840--------
Intrinsic Value_1Y_min---80.036--------
Intrinsic Value_3Y_max---138.547--------
Intrinsic Value_3Y_min---379.316--------
Intrinsic Value_5Y_max---320.065--------
Intrinsic Value_5Y_min---828.466--------
Market Cap251710176768.000-1034%2853546063360.0002233616296320.000+28%2370686194560.000+20%1841471778355.200+55%1106590210291.200+158%
Net Profit Margin---0.219-0.125-43%0.282-178%0.058-480%0.041-637%
Operating Margin----0%0.157-100%0.085-100%0.047-100%
Operating Ratio--1.6671.577+6%1.611+3%1.471+13%0.954+75%
Pb Ratio0.705-1034%7.9925.705+40%9.775-18%9.038-12%6.300+27%
Pe Ratio-1.584+91%-17.958-34.210+90%77.415-123%2.094-958%82.297-122%
Price Per Share101.000-1034%1145.000896.250+28%951.250+20%738.900+55%444.025+158%
Price To Free Cash Flow Ratio-0.583+91%-6.606-7.225+9%-6.544-1%25.528-126%12.122-154%
Price To Total Gains Ratio-6.361+91%-72.114-136.906+90%306.911-123%-28.794-60%208.672-135%
Quick Ratio--0.6420.827-22%1.465-56%2.046-69%1.540-58%
Return On Assets---0.026-0.014-46%0.046-157%0.015-279%0.011-329%
Return On Equity---0.111-0.056-50%0.159-170%0.034-430%0.024-572%
Total Gains Per Share---15.878-8.533-46%27.589-158%4.949-421%2.814-664%
Usd Book Value--35705970.39839723624.890-10%31099320.897+15%22832227.914+56%16600319.105+115%
Usd Book Value Change Per Share---0.002-0.001-46%0.003-158%0.000-432%0.000-701%
Usd Book Value Per Share--0.0140.016-10%0.012+15%0.009+56%0.007+115%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.002-0.001-46%0.003-158%0.000-442%0.000-710%
Usd Free Cash Flow---10799620.618-3191084.771-70%-1024635.967-91%-1718292.493-84%-694656.819-94%
Usd Free Cash Flow Per Share---0.004-0.001-70%0.000-91%-0.001-84%0.000-92%
Usd Free Cash Flow To Equity Per Share---0.004-0.002-58%0.007-158%0.002-338%0.001-457%
Usd Market Cap25171017.677-1034%285354606.336223361629.632+28%237068619.456+20%184147177.836+55%110659021.029+158%
Usd Price Per Share0.010-1034%0.1150.090+28%0.095+20%0.074+55%0.044+158%
Usd Profit---3972436.793-2130524.373-46%6881032.758-158%1134731.809-450%638442.473-722%
Usd Revenue--18159289.97117551690.390+3%17885625.677+2%12862678.565+41%9268693.283+96%
Usd Total Gains Per Share---0.002-0.001-46%0.003-158%0.000-421%0.000-664%
 EOD+3 -5MRQTTM+6 -26YOY+12 -215Y+10 -2510Y+11 -25

3.2. Fundamental Score

Let's check the fundamental score of Pyridam Farma Tbk based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.584
Price to Book Ratio (EOD)Between0-10.705
Net Profit Margin (MRQ)Greater than0-0.219
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.642
Current Ratio (MRQ)Greater than11.942
Debt to Asset Ratio (MRQ)Less than10.765
Debt to Equity Ratio (MRQ)Less than13.263
Return on Equity (MRQ)Greater than0.15-0.111
Return on Assets (MRQ)Greater than0.05-0.026
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Pyridam Farma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.047
Ma 20Greater thanMa 50633.700
Ma 50Greater thanMa 100725.780
Ma 100Greater thanMa 200887.890
OpenGreater thanClose100.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in IDR. All numbers in thousands.

Summary
Total Assets1,521,232,660
Total Liabilities1,164,172,956
Total Stockholder Equity356,833,920
 As reported
Total Liabilities 1,164,172,956
Total Stockholder Equity+ 356,833,920
Total Assets = 1,521,232,660

Assets

Total Assets1,521,232,660
Total Current Assets570,538,460
Long-term Assets950,694,200
Total Current Assets
Cash And Cash Equivalents 89,969,783
Net Receivables 188,691,462
Inventory 225,484,173
Total Current Assets  (as reported)570,538,460
Total Current Assets  (calculated)504,145,419
+/- 66,393,042
Long-term Assets
Property Plant Equipment 810,246,497
Intangible Assets 19,111,296
Long-term Assets Other 3,889,464
Long-term Assets  (as reported)950,694,200
Long-term Assets  (calculated)833,247,258
+/- 117,446,942

Liabilities & Shareholders' Equity

Total Current Liabilities293,714,678
Long-term Liabilities870,458,279
Total Stockholder Equity356,833,920
Total Current Liabilities
Short Long Term Debt 145,485,086
Accounts payable 62,845,539
Total Current Liabilities  (as reported)293,714,678
Total Current Liabilities  (calculated)208,330,625
+/- 85,384,052
Long-term Liabilities
Long term Debt 830,408,348
Capital Lease Obligations Min Short Term Debt11,097,849
Long-term Liabilities  (as reported)870,458,279
Long-term Liabilities  (calculated)841,506,197
+/- 28,952,082
Total Stockholder Equity
Retained Earnings 285,447,450
Total Stockholder Equity (as reported)356,833,920
Total Stockholder Equity (calculated)285,447,450
+/- 71,386,470
Other
Capital Stock53,508,000
Common Stock Shares Outstanding 535,080
Net Debt 885,923,651
Net Invested Capital 1,332,727,354
Net Working Capital 276,823,783
Property Plant and Equipment Gross 1,251,558,102



Balance Sheet

Currency in IDR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-30
> Total Assets 
75,631,000
69,750,895
69,523,000
68,267,470
71,662,916
70,788,811
70,144,856
70,429,781
73,133,806
74,122,285
75,704,473
76,550,878
81,040,146
81,209,054
81,771,600
89,327,678
89,389,921
88,438,831
95,157,347
95,074,065
97,962,638
99,234,847
98,655,309
105,195,081
105,010,511
100,152,388
99,937,383
106,482,845
0
104,219,092
100,586,999
107,050,667
109,755,037
113,228,978
118,033,603
119,544,083
121,841,581
131,065,428
135,849,510
141,765,873
158,723,307
167,723,883
175,118,921
181,824,178
173,147,162
170,146,377
172,736,625
174,123,281
174,711,025
170,341,298
159,951,537
162,649,989
166,966,179
160,129,483
167,062,796
168,707,400
165,649,965
164,011,719
159,563,931
183,202,355
184,797,067
187,451,862
187,057,164
191,306,461
184,442,804
189,742,144
190,786,208
205,050,055
201,228,762
218,611,308
228,575,381
569,150,707
577,963,244
627,532,095
806,221,575
1,243,728,581
1,224,176,717
1,516,966,153
1,520,568,654
1,488,163,011
1,515,035,073
1,558,244,360
1,521,232,660
1,521,232,6601,558,244,3601,515,035,0731,488,163,0111,520,568,6541,516,966,1531,224,176,7171,243,728,581806,221,575627,532,095577,963,244569,150,707228,575,381218,611,308201,228,762205,050,055190,786,208189,742,144184,442,804191,306,461187,057,164187,451,862184,797,067183,202,355159,563,931164,011,719165,649,965168,707,400167,062,796160,129,483166,966,179162,649,989159,951,537170,341,298174,711,025174,123,281172,736,625170,146,377173,147,162181,824,178175,118,921167,723,883158,723,307141,765,873135,849,510131,065,428121,841,581119,544,083118,033,603113,228,978109,755,037107,050,667100,586,999104,219,0920106,482,84599,937,383100,152,388105,010,511105,195,08198,655,30999,234,84797,962,63895,074,06595,157,34788,438,83189,389,92189,327,67881,771,60081,209,05481,040,14676,550,87875,704,47374,122,28573,133,80670,429,78170,144,85670,788,81171,662,91668,267,47069,523,00069,750,89575,631,000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,311,885
91,387,137
96,452,643
90,427,300
95,352,176
95,946,419
109,882,803
106,629,215
124,549,693
129,342,421
454,867,819
454,867,819
379,182,113
326,430,906
761,646,919
707,836,381
535,329,293
540,992,487
512,536,141
546,319,433
599,924,863
570,538,460
570,538,460599,924,863546,319,433512,536,141540,992,487535,329,293707,836,381761,646,919326,430,906379,182,113454,867,819454,867,819129,342,421124,549,693106,629,215109,882,80395,946,41995,352,17690,427,30096,452,64391,387,13794,311,8850000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,519,339
1,953,299
1,803,272
2,026,940
1,591,458
5,294,803
6,064,580
8,338,297
3,659,933
9,635,895
23,258,686
10,104,783
42,296,660
47,733,236
430,972,504
379,248,266
123,470,835
136,579,597
69,011,706
63,786,859
121,767,704
89,969,783
89,969,783121,767,70463,786,85969,011,706136,579,597123,470,835379,248,266430,972,50447,733,23642,296,66010,104,78323,258,6869,635,8953,659,9338,338,2976,064,5805,294,8031,591,4582,026,9401,803,2721,953,2991,519,3390000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
273,665,423
256,699,514
80,945,964
0
0
0
0
0
0
0
0
0
00000000080,945,964256,699,514273,665,42300000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
7,912,000
6,366,615
4,702,000
4,722,615
8,495,733
5,260,744
5,191,810
5,690,590
6,620,546
6,332,308
7,943,537
8,404,907
11,175,447
10,438,382
11,296,400
17,499,075
14,769,820
14,231,204
17,022,019
17,230,935
19,072,997
20,707,316
19,736,312
20,051,215
20,808,950
22,120,922
17,827,275
24,155,818
0
20,029,499
20,587,474
25,855,677
23,105,791
23,486,050
24,057,783
27,418,465
25,605,254
25,705,257
30,568,282
24,979,362
23,658,296
33,346,580
30,273,752
37,826,331
30,543,856
35,842,410
39,596,939
36,145,884
35,310,507
35,300,129
30,245,570
34,644,788
42,163,418
33,270,065
38,716,266
40,605,854
43,791,388
43,757,975
37,327,885
46,615,030
44,812,229
46,182,673
42,692,622
47,271,474
41,354,373
45,535,101
41,965,007
57,540,379
32,970,865
53,569,055
60,333,861
98,067,046
98,067,046
97,804,335
100,991,214
141,346,996
121,346,446
176,389,070
148,947,621
160,357,272
189,462,712
192,232,008
188,691,462
188,691,462192,232,008189,462,712160,357,272148,947,621176,389,070121,346,446141,346,996100,991,21497,804,33598,067,04698,067,04660,333,86153,569,05532,970,86557,540,37941,965,00745,535,10141,354,37347,271,47442,692,62246,182,67344,812,22946,615,03037,327,88543,757,97543,791,38840,605,85438,716,26633,270,06542,163,41834,644,78830,245,57035,300,12935,310,50736,145,88439,596,93935,842,41030,543,85637,826,33130,273,75233,346,58023,658,29624,979,36230,568,28225,705,25725,605,25427,418,46524,057,78323,486,05023,105,79125,855,67720,587,47420,029,499024,155,81817,827,27522,120,92220,808,95020,051,21519,736,31220,707,31619,072,99717,230,93517,022,01914,231,20414,769,82017,499,07511,296,40010,438,38211,175,4478,404,9077,943,5376,332,3086,620,5465,690,5905,191,8105,260,7448,495,7334,722,6154,702,0006,366,6157,912,000
       Other Current Assets 
4,443,000
700,606
842,000
906,563
84,844
307,120
545,551
719,701
895,861
513,966
862,275
867,693
1,396,369
554,178
958,443
3,235,006
2,958,176
1,721,836
3,020,591
3,405,748
2,151,307
2,801,718
1,831,104
1,334,360
545,731
648,864
462,648
756,299
0
1,049,229
1,304,096
1,317,043
1,135,858
1,480,595
3,787,735
2,646,307
5,118,544
9,273,613
7,629,363
18,988,749
27,709,459
1,691,998
1,266,666
1,957,158
4,219,723
3,396,978
3,296,192
6,422,123
3,136,458
3,712,331
2,608,786
5,940,704
3,602,949
3,550,819
2,723,939
4,413,957
5,113,169
4,523,205
3,765,799
6,361,382
7,706,310
7,463,377
4,459,406
6,120,567
9,452,025
7,234,595
3,590,047
3,969,036
6,786,755
11,066,397
7,696,828
15,839,266
15,839,266
68,672,447
24,118,499
27,058,765
34,578,354
28,261,694
0
0
0
88,000
0
088,00000028,261,69434,578,35427,058,76524,118,49968,672,44715,839,26615,839,2667,696,82811,066,3976,786,7553,969,0363,590,0477,234,5959,452,0256,120,5674,459,4067,463,3777,706,3106,361,3823,765,7994,523,2055,113,1694,413,9572,723,9393,550,8193,602,9495,940,7042,608,7863,712,3313,136,4586,422,1233,296,1923,396,9784,219,7231,957,1581,266,6661,691,99827,709,45918,988,7497,629,3639,273,6135,118,5442,646,3073,787,7351,480,5951,135,8581,317,0431,304,0961,049,2290756,299462,648648,864545,7311,334,3601,831,1042,801,7182,151,3073,405,7483,020,5911,721,8362,958,1763,235,006958,443554,1781,396,369867,693862,275513,966895,861719,701545,551307,12084,844906,563842,000700,6064,443,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,853,818
94,015,505
94,389,968
94,839,789
95,167,252
94,599,548
94,061,615
99,232,960
97,494,587
123,095,424
248,349,981
479,790,670
482,081,662
516,340,336
981,636,860
979,576,167
975,626,871
968,715,639
958,319,498
950,694,200
950,694,200958,319,498968,715,639975,626,871979,576,167981,636,860516,340,336482,081,662479,790,670248,349,981123,095,42497,494,58799,232,96094,061,61594,599,54895,167,25294,839,78994,389,96894,015,50594,853,818000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
56,307,000
56,262,326
56,576,000
56,314,303
56,626,833
56,615,010
56,563,845
57,492,409
56,998,029
57,632,923
58,736,889
58,543,562
58,773,132
59,399,884
59,094,193
58,567,261
58,971,556
59,344,709
53,949,642
58,932,151
57,525,086
56,520,069
56,679,611
57,000,867
57,085,673
55,727,377
54,047,385
53,533,370
0
52,889,772
52,826,676
55,110,114
54,070,982
53,515,739
55,114,228
54,554,966
56,767,180
58,352,888
66,153,646
71,951,327
78,616,133
98,897,226
97,554,475
97,551,663
94,759,926
93,686,745
91,716,052
89,130,104
88,506,670
86,256,249
84,152,132
83,245,420
81,628,666
79,428,964
79,954,783
78,378,039
76,527,983
76,759,759
75,929,987
87,166,512
86,491,778
87,424,979
90,377,680
89,358,570
88,409,424
88,725,903
88,397,890
88,703,913
88,083,019
87,483,171
96,247,182
92,284,915
92,284,915
104,408,096
386,757,280
388,367,732
399,747,298
813,114,249
846,694,435
838,760,632
827,296,716
816,231,949
810,246,497
810,246,497816,231,949827,296,716838,760,632846,694,435813,114,249399,747,298388,367,732386,757,280104,408,09692,284,91592,284,91596,247,18287,483,17188,083,01988,703,91388,397,89088,725,90388,409,42489,358,57090,377,68087,424,97986,491,77887,166,51275,929,98776,759,75976,527,98378,378,03979,954,78379,428,96481,628,66683,245,42084,152,13286,256,24988,506,67089,130,10491,716,05293,686,74594,759,92697,551,66397,554,47598,897,22678,616,13371,951,32766,153,64658,352,88856,767,18054,554,96655,114,22853,515,73954,070,98255,110,11452,826,67652,889,772053,533,37054,047,38555,727,37757,085,67357,000,86756,679,61156,520,06957,525,08658,932,15153,949,64259,344,70958,971,55658,567,26159,094,19359,399,88458,773,13258,543,56258,736,88957,632,92356,998,02957,492,40956,563,84556,615,01056,626,83356,314,30356,576,00056,262,32656,307,000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,446,932
42,446,932
42,446,932
42,446,932
0
0
0
0
0
0000042,446,93242,446,93242,446,93242,446,93200000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
12,261
12,000
11,090
16,101
21,991
21,446
20,915
26,685
26,018
25,351
24,683
24,066
23,449
22,832
43,591
41,694
39,796
5,816,381
44,128
42,748
41,368
39,891
38,889
37,890
36,890
35,890
34,991
0
33,191
32,291
31,481
30,672
29,862
29,052
28,326
27,600
67,543
65,788
64,143
85,411
83,179
80,947
107,038
102,687
99,682
97,002
92,918
91,107
89,297
99,674
115,231
107,251
102,785
96,685
94,268
91,851
102,770
100,017
94,843
95,911
124,800
121,481
153,152
149,240
145,328
141,416
137,881
134,345
175,552
266,142
254,717
2,243,292
2,181,867
2,383,313
2,321,888
2,415,963
51,997,057
11,170,212
15,946,724
20,264,842
19,766,869
19,111,296
19,111,29619,766,86920,264,84215,946,72411,170,21251,997,0572,415,9632,321,8882,383,3132,181,8672,243,292254,717266,142175,552134,345137,881141,416145,328149,240153,152121,481124,80095,91194,843100,017102,77091,85194,26896,685102,785107,251115,23199,67489,29791,10792,91897,00299,682102,687107,03880,94783,17985,41164,14365,78867,54327,60028,32629,05229,86230,67231,48132,29133,191034,99135,89036,89037,89038,88939,89141,36842,74844,1285,816,38139,79641,69443,59122,83223,44924,06624,68325,35126,01826,68520,91521,44621,99116,10111,09012,00012,2610
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,853,818
94,015,505
94,389,968
94,839,789
95,167,252
2,361,111
0
0
0
0
3,964,338
1,605,966
1,605,966
1,627,337
3,559,092
4,356,181
3,939,058
3,803,897
3,716,361
3,889,464
3,889,4643,716,3613,803,8973,939,0584,356,1813,559,0921,627,3371,605,9661,605,9663,964,33800002,361,11195,167,25294,839,78994,389,96894,015,50594,853,818000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
13,538,000
9,658,448
8,896,000
7,556,315
9,749,139
8,308,273
7,641,070
8,286,936
9,975,984
10,582,765
12,216,437
13,079,611
16,325,615
16,793,525
17,059,604
22,783,796
23,815,686
22,233,610
28,213,190
27,391,875
28,291,421
27,776,199
29,402,275
32,629,623
30,909,464
27,120,564
26,911,380
29,149,381
0
25,939,386
23,361,793
25,190,282
26,556,026
30,825,405
35,636,351
34,393,404
36,035,804
44,682,486
48,144,037
52,510,531
69,453,517
77,730,974
81,217,648
86,245,663
78,728,012
75,819,037
76,177,686
76,436,561
76,800,710
73,064,002
58,729,478
60,478,387
63,096,406
56,066,049
61,554,005
61,887,508
60,462,301
54,928,405
50,707,930
72,709,634
74,234,042
74,293,912
68,129,603
70,493,079
65,890,526
68,029,994
66,060,215
75,957,469
70,805,618
77,764,424
70,943,631
404,085,389
403,350,353
444,581,289
639,121,008
1,074,133,289
1,047,782,448
1,061,109,154
1,078,442,377
1,058,348,166
1,109,594,297
1,161,614,691
1,164,172,956
1,164,172,9561,161,614,6911,109,594,2971,058,348,1661,078,442,3771,061,109,1541,047,782,4481,074,133,289639,121,008444,581,289403,350,353404,085,38970,943,63177,764,42470,805,61875,957,46966,060,21568,029,99465,890,52670,493,07968,129,60374,293,91274,234,04272,709,63450,707,93054,928,40560,462,30161,887,50861,554,00556,066,04963,096,40660,478,38758,729,47873,064,00276,800,71076,436,56176,177,68675,819,03778,728,01286,245,66381,217,64877,730,97469,453,51752,510,53148,144,03744,682,48636,035,80434,393,40435,636,35130,825,40526,556,02625,190,28223,361,79325,939,386029,149,38126,911,38027,120,56430,909,46432,629,62329,402,27527,776,19928,291,42127,391,87528,213,19022,233,61023,815,68622,783,79617,059,60416,793,52516,325,61513,079,61112,216,43710,582,7659,975,9848,286,9367,641,0708,308,2739,749,1397,556,3158,896,0009,658,44813,538,000
   > Total Current Liabilities 
8,659,000
7,395,121
6,215,000
7,306,848
9,262,105
7,653,018
6,924,535
7,956,167
9,608,720
10,214,597
11,074,558
12,611,725
15,380,891
15,300,019
15,440,756
20,248,453
21,681,508
19,924,237
24,017,739
26,318,477
23,517,673
23,118,647
25,112,131
27,563,650
26,169,205
22,098,711
21,669,515
23,418,497
0
19,224,336
15,645,371
15,980,573
16,674,131
20,450,676
24,366,695
22,845,376
19,390,099
22,709,336
28,419,830
22,693,565
29,394,210
37,104,695
48,785,877
52,624,985
44,441,483
44,212,960
47,994,726
47,486,954
46,974,601
42,564,196
36,534,059
37,434,172
39,277,763
31,236,042
37,933,579
37,404,327
35,662,862
30,049,007
22,245,116
43,254,222
36,299,112
34,978,414
33,141,647
34,185,141
28,443,593
28,653,803
27,198,123
35,712,992
30,027,043
36,883,070
44,748,565
80,132,433
80,132,433
115,054,576
251,838,113
293,761,026
270,960,151
271,438,740
297,388,369
280,084,224
334,191,076
288,575,745
293,714,678
293,714,678288,575,745334,191,076280,084,224297,388,369271,438,740270,960,151293,761,026251,838,113115,054,57680,132,43380,132,43344,748,56536,883,07030,027,04335,712,99227,198,12328,653,80328,443,59334,185,14133,141,64734,978,41436,299,11243,254,22222,245,11630,049,00735,662,86237,404,32737,933,57931,236,04239,277,76337,434,17236,534,05942,564,19646,974,60147,486,95447,994,72644,212,96044,441,48352,624,98548,785,87737,104,69529,394,21022,693,56528,419,83022,709,33619,390,09922,845,37624,366,69520,450,67616,674,13115,980,57315,645,37119,224,336023,418,49721,669,51522,098,71126,169,20527,563,65025,112,13123,118,64723,517,67326,318,47724,017,73919,924,23721,681,50820,248,45315,440,75615,300,01915,380,89112,611,72511,074,55810,214,5979,608,7207,956,1676,924,5357,653,0189,262,1057,306,8486,215,0007,395,1218,659,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,536
1,202,143
19,514,519
601,071
14,271,230
10,404,472
10,800,000
10,800,000
14,800,000
21,467,648
16,500,000
19,403,865
28,500,000
65,000,000
112,282,041
138,140,953
126,947,491
137,429,090
88,401,253
133,102,797
127,915,262
0
0127,915,262133,102,79788,401,253137,429,090126,947,491138,140,953112,282,04165,000,00028,500,00019,403,86516,500,00021,467,64814,800,00010,800,00010,800,00010,404,47214,271,230601,07119,514,5191,202,143300,5360000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,536
1,202,143
18,651,093
17,109,314
13,849,529
11,606,615
11,801,786
11,401,071
15,100,536
22,669,791
17,401,607
20,105,115
31,264,643
80,858,243
128,140,284
153,999,195
142,805,734
154,131,083
104,868,896
148,922,040
141,929,905
145,485,086
145,485,086141,929,905148,922,040104,868,896154,131,083142,805,734153,999,195128,140,28480,858,24331,264,64320,105,11517,401,60722,669,79115,100,53611,401,07111,801,78611,606,61513,849,52917,109,31418,651,0931,202,143300,5360000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
302,487
904,000
251,458
1,196,028
902,096
497,149
877,524
1,845,173
984,360
1,000,399
1,090,539
1,829,408
1,046,742
1,165,526
3,228,238
2,533,233
639,039
5,806,232
4,827,770
1,920,896
5,107,845
2,168,366
5,176,781
4,115,162
2,307,780
2,921,826
4,732,751
0
1,638,517
1,549,729
2,221,303
3,914,744
3,013,152
2,541,803
3,941,766
1,834,724
2,986,223
1,190,638
2,896,037
3,547,625
5,926,575
7,088,178
8,239,164
5,134,783
4,918,357
6,590,591
7,772,560
7,708,888
5,201,665
3,629,434
4,843,231
7,106,008
7,296,786
5,980,507
3,628,174
3,814,634
7,309,190
6,737,016
7,176,852
7,094,798
7,215,789
8,744,640
6,485,603
4,708,429
6,694,777
8,493,646
10,541,475
9,912,736
7,880,169
9,259,127
39,903,326
39,903,326
31,787,914
95,400,486
80,112,219
74,810,923
65,267,089
68,693,526
91,602,792
98,616,225
74,225,428
62,845,539
62,845,53974,225,42898,616,22591,602,79268,693,52665,267,08974,810,92380,112,21995,400,48631,787,91439,903,32639,903,3269,259,1277,880,1699,912,73610,541,4758,493,6466,694,7774,708,4296,485,6038,744,6407,215,7897,094,7987,176,8526,737,0167,309,1903,814,6343,628,1745,980,5077,296,7867,106,0084,843,2313,629,4345,201,6657,708,8887,772,5606,590,5914,918,3575,134,7838,239,1647,088,1785,926,5753,547,6252,896,0371,190,6382,986,2231,834,7243,941,7662,541,8033,013,1523,914,7442,221,3031,549,7291,638,51704,732,7512,921,8262,307,7804,115,1625,176,7812,168,3665,107,8451,920,8964,827,7705,806,232639,0392,533,2333,228,2381,165,5261,046,7421,829,4081,090,5391,000,399984,3601,845,173877,524497,149902,0961,196,028251,458904,000302,4870
       Other Current Liabilities 
0
2,883,695
2,002,000
2,278,385
3,918,243
3,525,815
3,482,139
2,786,209
3,063,205
3,133,611
3,128,376
3,605,072
5,055,469
5,673,991
5,813,256
5,637,020
5,396,327
6,267,107
2,762,079
7,400,263
6,956,213
7,985,267
5,302,869
8,697,610
8,295,598
7,462,304
3,179,184
6,496,840
0
7,716,241
4,963,034
6,502,560
7,511,912
8,758,147
7,143,222
7,306,909
4,424,264
4,763,265
4,856,315
6,840,085
4,488,770
6,699,501
9,320,010
12,854,115
8,187,163
5,488,384
4,816,629
6,104,824
7,648,451
6,316,041
3,528,196
10,236,572
7,805,674
5,156,405
5,081,109
4,574,147
4,688,232
6,423,964
5,753,281
8,127,087
3,211,443
1,133,843
2,913,599
2,531,801
2,705,966
1,245,501
2,667,546
3,438,211
1,182,208
5,482,196
5,835,970
2,519,811
2,519,811
33,569,055
53,244,146
55,798,274
19,204,871
27,501,503
17,175,529
0
28,891,476
0
0
0028,891,476017,175,52927,501,50319,204,87155,798,27453,244,14633,569,0552,519,8112,519,8115,835,9705,482,1961,182,2083,438,2112,667,5461,245,5012,705,9662,531,8012,913,5991,133,8433,211,4438,127,0875,753,2816,423,9644,688,2324,574,1475,081,1095,156,4057,805,67410,236,5723,528,1966,316,0417,648,4516,104,8244,816,6295,488,3848,187,16312,854,1159,320,0106,699,5014,488,7706,840,0854,856,3154,763,2654,424,2647,306,9097,143,2228,758,1477,511,9126,502,5604,963,0347,716,24106,496,8403,179,1847,462,3048,295,5988,697,6105,302,8697,985,2676,956,2137,400,2632,762,0796,267,1075,396,3275,637,0205,813,2565,673,9915,055,4693,605,0723,128,3763,133,6113,063,2052,786,2093,482,1393,525,8153,918,2432,278,3852,002,0002,883,6950
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,307,938
37,446,932
39,376,191
38,862,091
40,244,477
40,778,575
40,881,353
26,195,065
324,426,352
323,217,919
329,526,223
387,282,895
780,372,263
776,822,297
789,478,429
780,822,798
778,042,603
775,183,669
872,814,402
870,458,279
870,458,279872,814,402775,183,669778,042,603780,822,798789,478,429776,822,297780,372,263387,282,895329,526,223323,217,919324,426,35226,195,06540,881,35340,778,57540,244,47738,862,09139,376,19137,446,93236,307,938000000000000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,073,986
6,923,986
7,523,986
7,077,736
8,007,953
304,896,004
305,041,804
312,353,853
362,803,168
755,821,401
752,787,355
751,106,942
750,231,220
747,538,325
743,586,194
839,747,919
0
0839,747,919743,586,194747,538,325750,231,220751,106,942752,787,355755,821,401362,803,168312,353,853305,041,804304,896,0048,007,9537,077,7367,523,9866,923,9866,073,986000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-300,536
-1,202,143
-19,514,519
248,929
-14,271,230
-10,404,472
-9,100,000
-9,125,000
-12,387,810
-12,531,740
-7,777,695
-12,440,348
-23,011,592
-51,054,429
-98,626,817
-123,361,039
-111,927,267
-123,546,045
-75,814,212
-121,795,202
-116,448,723
11,097,849
11,097,849-116,448,723-121,795,202-75,814,212-123,546,045-111,927,267-123,361,039-98,626,817-51,054,429-23,011,592-12,440,348-7,777,695-12,531,740-12,387,810-9,125,000-9,100,000-10,404,472-14,271,230248,929-19,514,519-1,202,143-300,5360000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200,000
0
0200,000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
62,093,000
60,092,447
60,627,000
60,711,155
61,913,778
62,480,539
62,503,787
62,142,845
63,157,822
63,539,521
63,488,036
63,471,267
64,714,531
64,415,529
64,711,996
66,543,882
65,574,235
66,205,220
66,944,157
67,682,190
69,671,217
71,458,648
69,253,035
72,565,459
74,101,046
73,031,824
73,026,003
77,333,464
77,333,464
78,279,706
77,225,206
81,860,385
83,199,012
82,403,573
82,397,252
85,150,679
85,805,777
86,382,942
87,705,473
89,255,342
89,269,790
89,992,909
93,901,273
95,578,515
94,419,150
94,327,340
96,558,939
97,686,720
97,910,315
97,277,295
101,222,059
102,171,602
103,869,773
104,063,434
105,508,790
106,819,892
105,187,664
109,083,314
108,856,001
110,492,721
110,563,025
113,157,950
118,927,561
120,813,383
118,552,279
121,712,150
124,725,994
129,092,585
130,423,145
140,846,884
157,631,750
165,065,318
174,612,891
182,950,806
167,100,058
169,596,054
176,151,691
455,856,999
442,126,277
429,814,846
405,440,776
396,629,670
356,833,920
356,833,920396,629,670405,440,776429,814,846442,126,277455,856,999176,151,691169,596,054167,100,058182,950,806174,612,891165,065,318157,631,750140,846,884130,423,145129,092,585124,725,994121,712,150118,552,279120,813,383118,927,561113,157,950110,563,025110,492,721108,856,001109,083,314105,187,664106,819,892105,508,790104,063,434103,869,773102,171,602101,222,05997,277,29597,910,31597,686,72096,558,93994,327,34094,419,15095,578,51593,901,27389,992,90989,269,79089,255,34287,705,47386,382,94285,805,77785,150,67982,397,25282,403,57383,199,01281,860,38577,225,20678,279,70677,333,46477,333,46473,026,00373,031,82474,101,04672,565,45969,253,03571,458,64869,671,21767,682,19066,944,15766,205,22065,574,23566,543,88264,711,99664,415,52964,714,53163,471,26763,488,03663,539,52163,157,82262,142,84562,503,78762,480,53961,913,77860,711,15560,627,00060,092,44762,093,000
   Common Stock
52,000,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
0
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
53,508,000
0
053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,000053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00053,508,00052,000,000
   Retained Earnings 
11,043,000
4,519,368
5,054,000
5,138,076
6,340,699
6,907,460
6,930,708
6,569,766
7,584,744
7,966,442
7,914,957
7,898,189
9,141,452
8,842,451
9,138,918
10,970,804
10,001,156
10,632,142
11,371,079
12,109,112
14,098,138
15,885,570
13,679,956
16,992,380
18,527,968
17,458,746
17,452,924
21,760,386
0
22,706,628
21,652,127
26,287,306
27,625,933
26,830,494
26,824,173
29,577,601
30,232,698
30,809,864
32,132,394
33,682,263
33,696,711
34,419,831
38,328,195
40,005,436
38,846,071
38,754,262
40,985,860
42,113,641
42,337,237
41,704,217
45,648,981
46,598,523
48,296,695
48,490,355
49,935,712
51,246,813
49,614,585
53,510,236
53,282,922
54,919,642
54,989,946
57,584,872
63,354,482
63,240,304
60,979,200
64,139,072
69,152,915
73,519,507
74,850,066
85,273,805
91,948,171
103,313,798
103,313,798
107,912,323
97,427,115
99,923,111
106,478,768
386,184,056
372,668,425
360,356,321
335,982,253
327,171,818
285,447,450
285,447,450327,171,818335,982,253360,356,321372,668,425386,184,056106,478,76899,923,11197,427,115107,912,323103,313,798103,313,79891,948,17185,273,80574,850,06673,519,50769,152,91564,139,07260,979,20063,240,30463,354,48257,584,87254,989,94654,919,64253,282,92253,510,23649,614,58551,246,81349,935,71248,490,35548,296,69546,598,52345,648,98141,704,21742,337,23742,113,64140,985,86038,754,26238,846,07140,005,43638,328,19534,419,83133,696,71133,682,26332,132,39430,809,86430,232,69829,577,60126,824,17326,830,49427,625,93326,287,30621,652,12722,706,628021,760,38617,452,92417,458,74618,527,96816,992,38013,679,95615,885,57014,098,13812,109,11211,371,07910,632,14210,001,15610,970,8049,138,9188,842,4519,141,4527,898,1897,914,9577,966,4427,584,7446,569,7666,930,7086,907,4606,340,6995,138,0765,054,0004,519,36811,043,000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,065,079
2,065,079
2,065,079
2,065,079
2,065,079
2,065,079
2,065,079
2,065,079
2,065,085
2,065,085
2,065,065
2,065,085
2,064,410
2,065,083
2,065,082
2,064,410
0
02,064,4102,065,0822,065,0832,064,4102,065,0852,065,0652,065,0852,065,0852,065,0792,065,0792,065,0792,065,0792,065,0792,065,0792,065,0792,065,079000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,110,501
15,726,014
15,726,014
19,465,404
14,099,858
14,099,858
14,099,858
14,099,858
13,885,441
13,885,441
13,885,441
13,885,441
0
013,885,44113,885,44113,885,44113,885,44114,099,85814,099,85814,099,85814,099,85819,465,40415,726,01415,726,01410,110,5010000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in IDR. All numbers in thousands.




Cash Flow

Currency in IDR. All numbers in thousands.




Income Statement

Currency in IDR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue702,067,616
Cost of Revenue-406,752,079
Gross Profit295,315,537295,315,537
 
Operating Income (+$)
Gross Profit295,315,537
Operating Expense-698,506,719
Operating Income3,560,897-403,191,182
 
Operating Expense (+$)
Research Development17,765,487
Selling General Administrative150,135,543
Selling And Marketing Expenses0
Operating Expense698,506,719167,901,030
 
Net Interest Income (+$)
Interest Income1,371,961
Interest Expense-85,794,560
Other Finance Cost-704,844
Net Interest Income-85,127,443
 
Pretax Income (+$)
Operating Income3,560,897
Net Interest Income-85,127,443
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-83,247,9523,560,897
EBIT - interestExpense = -85,794,560
-85,220,975
573,585
Interest Expense85,794,560
Earnings Before Interest and Taxes (EBIT)02,546,608
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-83,247,952
Tax Provision-1,978,526
Net Income From Continuing Ops-85,226,477-85,226,477
Net Income-85,220,975
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net085,127,443
 

Technical Analysis of Pyridam Farma Tbk
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pyridam Farma Tbk. The general trend of Pyridam Farma Tbk is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pyridam Farma Tbk's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pyridam Farma Tbk.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 595.00 < 600.00 < 975.00.

The bearish price targets are: .

Tweet this
Pyridam Farma Tbk Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pyridam Farma Tbk. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pyridam Farma Tbk Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pyridam Farma Tbk. The current macd is -166.75673588.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pyridam Farma Tbk price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pyridam Farma Tbk. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pyridam Farma Tbk price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pyridam Farma Tbk Daily Moving Average Convergence/Divergence (MACD) ChartPyridam Farma Tbk Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pyridam Farma Tbk. The current adx is 27.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pyridam Farma Tbk shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Pyridam Farma Tbk Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pyridam Farma Tbk. The current sar is 817.46.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pyridam Farma Tbk Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pyridam Farma Tbk. The current rsi is 22.05. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Pyridam Farma Tbk Daily Relative Strength Index (RSI) ChartPyridam Farma Tbk Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pyridam Farma Tbk. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pyridam Farma Tbk price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Pyridam Farma Tbk Daily Stochastic Oscillator ChartPyridam Farma Tbk Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pyridam Farma Tbk. The current cci is -142.31542458.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pyridam Farma Tbk Daily Commodity Channel Index (CCI) ChartPyridam Farma Tbk Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pyridam Farma Tbk. The current cmo is -65.25716323.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pyridam Farma Tbk Daily Chande Momentum Oscillator (CMO) ChartPyridam Farma Tbk Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pyridam Farma Tbk. The current willr is -99.90654206.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pyridam Farma Tbk Daily Williams %R ChartPyridam Farma Tbk Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pyridam Farma Tbk.

Pyridam Farma Tbk Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pyridam Farma Tbk. The current atr is 103.56.

Pyridam Farma Tbk Daily Average True Range (ATR) ChartPyridam Farma Tbk Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pyridam Farma Tbk. The current obv is -231,085,800.

Pyridam Farma Tbk Daily On-Balance Volume (OBV) ChartPyridam Farma Tbk Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pyridam Farma Tbk. The current mfi is 38.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pyridam Farma Tbk Daily Money Flow Index (MFI) ChartPyridam Farma Tbk Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pyridam Farma Tbk.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Pyridam Farma Tbk Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pyridam Farma Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.047
Ma 20Greater thanMa 50633.700
Ma 50Greater thanMa 100725.780
Ma 100Greater thanMa 200887.890
OpenGreater thanClose100.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pyridam Farma Tbk with someone you think should read this too:
  • Are you bullish or bearish on Pyridam Farma Tbk? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pyridam Farma Tbk? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pyridam Farma Tbk

I send you an email if I find something interesting about Pyridam Farma Tbk.


Comments

How you think about this?

Leave a comment

Stay informed about Pyridam Farma Tbk.

Receive notifications about Pyridam Farma Tbk in your mailbox!